Creative Capital Generation With James Thomas Coates, Ph.D.
Business Of Biotech
00:00
What Is Working?
Yel: There's a lot of creative options out there now. But maybe not all of it is a good idea, i'm sure some of this kind depends on what your goal is as a company and where you are on the continuum. We're seeing a lot of success for start ups, successfully getting grant money and contract money from the government to get early stage clinical trial execution and regulatory case. And so that's one thing that we see working very well. In terms of what's not working, i would say almost the inverse, in a way, when you are tapping shareholders without positive data, simple as that.
Transcript
Play full episode
